- Home
- SXTC vs DHF Comparison
SXTC vs DHF Comparison
Compare SXTC & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTC | DHF |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.5M | 185.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SXTC | DHF |
|---|---|---|
| Price | $1.40 | $2.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 224.2K | ★ 451.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.65% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,740,907.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.95 | $2.06 |
| 52 Week High | $7.84 | $2.39 |
Technical Indicators
Market Signals| Indicator | SXTC | DHF |
|---|---|---|
| Relative Strength Index (RSI) | 50.67 | 44.30 |
| Support Level | $1.35 | $2.49 |
| Resistance Level | $1.42 | $2.55 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 45.00 | 33.33 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.